EPFL Innovation Park - Where Aleva’s Innovation Was Born
EPFL Innovation Park - Where Aleva’s Innovation Was Born
Founded at the École Polytechnique Fédérale de Lausanne (EPFL) in 2008, Aleva originated from advanced research in microengineering and neurotechnology. The collaboration between EPFL scientists and neurosurgeons laid the scientific and technological foundations for the world’s first truly directional Deep Brain Stimulation system.
Founded at the École Polytechnique Fédérale de Lausanne (EPFL) in 2008, Aleva originated from advanced research in microengineering and neurotechnology. The collaboration between EPFL scientists and neurosurgeons laid the scientific and technological foundations for the world’s first truly directional Deep Brain Stimulation system.
Context
Context
EPFL remains integral to Aleva’s technological legacy. The institution’s Microsystems Laboratory and Centre of Neuroprosthetics provided the research environment that enabled the development of Aleva’s proprietary MEMS-based electrodes — the cornerstone of its precision neuromodulation platform.
EPFL remains integral to Aleva’s technological legacy. The institution’s Microsystems Laboratory and Centre of Neuroprosthetics provided the research environment that enabled the development of Aleva’s proprietary MEMS-based electrodes — the cornerstone of its precision neuromodulation platform.
EPFL remains integral to Aleva’s technological legacy. The institution’s Microsystems Laboratory and Centre of Neuroprosthetics provided the research environment that enabled the development of Aleva’s proprietary MEMS-based electrodes — the cornerstone of its precision neuromodulation platform.
SHARED ENDEAVOURS
SHARED ENDEAVOURS
Academic & Technological Research
Academic & Technological Research
A partnership defined by scientific curiosity, academic excellence, and a shared goal to translate engineering breakthroughs into clinical reality.
EPFL Overview
The École Polytechnique Fédérale de Lausanne (EPFL) is one of Europe’s leading institutes of technology and a global hub for innovation in neuroscience, microengineering, and life sciences. Its ecosystem fosters collaboration between academia and industry, turning fundamental discoveries into transformative medical technologies.
Partnership Highlights
The collaboration brought together EPFL’s world-class research infrastructure and Aleva’s applied engineering expertise. Joint development between EPFL’s Microsystems Laboratory and Aleva’s founding team produced the first MEMS-based electrode array suitable for long-term human implantation — a milestone in precision neuroengineering.
EPFL Overview
The École Polytechnique Fédérale de Lausanne (EPFL) is one of Europe’s leading institutes of technology and a global hub for innovation in neuroscience, microengineering, and life sciences. Its ecosystem fosters collaboration between academia and industry, turning fundamental discoveries into transformative medical technologies.
Partnership Highlights
The collaboration brought together EPFL’s world-class research infrastructure and Aleva’s applied engineering expertise. Joint development between EPFL’s Microsystems Laboratory and Aleva’s founding team produced the first MEMS-based electrode array suitable for long-term human implantation — a milestone in precision neuroengineering.
“Aleva’s story began in the lab, where curiosity met clinical need. EPFL provided the space — intellectual and physical — for that convergence.”
“Aleva’s story began in the lab, where curiosity met clinical need. EPFL provided the space — intellectual and physical — for that convergence.”
Prof. Philippe Renaud - Director of the Microsystems Lab 4 at EPFL
Prof. Philippe Renaud - Director of the Microsystems Lab 4 at EPFL
“Aleva’s story began in the lab, where curiosity met clinical need. EPFL provided the space — intellectual and physical — for that convergence.”
Prof. Philippe Renaud - Director of the Microsystems Lab 4 at EPFL
Impact & Shared Achievements
Together, EPFL and Aleva transformed academic research into a CE-marked medical technology, demonstrating the power of applied science to shape clinical practice. The partnership has since evolved into a model for translational innovation, bridging university research, regulatory validation, and commercial application in neuromodulation.
Impact & Shared Achievements
Together, EPFL and Aleva transformed academic research into a CE-marked medical technology, demonstrating the power of applied science to shape clinical practice. The partnership has since evolved into a model for translational innovation, bridging university research, regulatory validation, and commercial application in neuromodulation.